# FDA Inspection 1236034 - AstraZeneca Pharmaceuticals, LP - April 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/cb6c7779-21dd-4b19-95f1-398a71e54c1f
Source feed: FDA_Inspections

> FDA Inspection 1236034 for AstraZeneca Pharmaceuticals, LP on April 26, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236034
- Company Name: AstraZeneca Pharmaceuticals, LP
- Inspection Date: 2024-04-26
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1211584 - 2023-07-19](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/3c06a69b-bae4-4442-8515-ad030865c29e)
- [FDA Inspection 1022686 - 2017-08-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2212a7e-f3ac-42a5-ad63-1ca1b64cf950)
- [FDA Inspection 1022686 - 2017-08-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/6504f213-03f2-4da2-9d08-6b2de9882202)
- [FDA Inspection 895233 - 2014-08-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/85d228df-13a6-44d7-8489-95ab6bab3f22)
- [FDA Inspection 788561 - 2011-11-28](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/52f8236e-921e-485d-91d3-9461b11717a5)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/ebec0358-60f4-4d3d-88a0-f03f946518ea

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8